Back to RCM
Founder / Operator·RCM

Florian Otto

Co-Founder and CEO at Cedar

New York, New York

FO
LinkedIn
Why they matter

Operates the category-defining patient-billing platform, acquired a $425M competitor, and holds live payment-behavior data across major health systems: rare ground truth on RCM demand.

Background

Florian Otto is co-founder and CEO of Cedar, the New York-based patient financial engagement platform he started in 2016 after his wife received a confusing hospital bill. He holds an M.D., D.D.S. and PhD from the University of Freiburg and began his business career as a strategy consultant in McKinsey's healthcare practice. Before Cedar he founded Brazilian daily-deal company ClubeUrbano, which Groupon acquired, then served as CEO of Groupon Brazil, and later drove commercial adoption as an executive at Zocdoc.

Notable deals

  • 2021
    Closed a $200M Series D led by Tiger Global Management, valuing Cedar at $3.2 billion
  • 2021
    Acquired OODA Health for $425M, extending Cedar from provider-side billing into the payer market
  • 2025
    Signed Sanford Health, the largest rural health system in the US (2.4M patients), onto Cedar Pay
  • 2026
    Scaled Kora agentic AI voice agent to ~400,000 patient billing calls across ten provider organizations in year one

Call-prep brief

Background

  • M.D., D.D.S. and PhD (University of Freiburg); started in business at McKinsey's healthcare practice.
  • Founded ClubeUrbano in Brazil, sold it to Groupon, then ran Groupon Brazil as CEO; later a commercial executive at Zocdoc.
  • Co-founded Cedar in New York in 2016 after his wife's poor hospital billing experience.

Current focus

  • Product suite spans Cedar Pay, Cedar Cover and Kora, the agentic voice agent launched April 2025. By June 2026 Kora had handled roughly 400,000 patient calls across ten provider organizations, with reported results including a 24% cut in live-agent handle time at Gastro Health and a 42% lift in patient payments at ApolloMD.
  • Pushing beyond urban academic systems into rural care; the May 2025 Sanford Health partnership covers the largest rural system in the country.

What he cares about

  • Consumer-grade transparency: plain-language bills, real-time HSA balances surfaced at payment, personalized payment plans.
  • Measured outcomes over AI narrative. His own framing: "We have heard enough about AI promises."

Recent moves

  • $200M Series D (March 2021, Tiger Global) at $3.2B; $425M OODA Health acquisition closed June 2021, bringing payers onto the platform alongside providers.

Potential sensitivities

  • The $3.2B mark is a 2021 vintage and no new priced round has been announced since. Valuation and exit timing are live questions, not settled ones.
  • Cedar cut 24% of staff (roughly 100 people) in July 2022 while integrating OODA. Do not open there.

Ask him

  1. Is Kora deflecting call volume or just relocating it, and does that change how you price?
  2. Post-OODA, what is the payer-side versus provider-side revenue split, and which is compounding faster?
  3. Which RCM adjacencies would you buy today rather than build?

Outreach draft

Subject
Patient-pay economics in your RCM stack
Dr. Otto, I lead healthcare investing at [Firm], and we're underwriting the patient financial experience layer of RCM ahead of a possible platform investment. Cedar is the reference point in most of our diligence conversations, particularly since the OODA acquisition brought the payer side onto the same platform. What I'd most value is your read on where provider budgets are actually moving now that agentic tools like Kora are absorbing call volume, and whether that consolidates spend into fewer vendors or fragments it. Happy to share what we're seeing across our portfolio in return. Would 30 minutes in the next two weeks work? Best, [Your Name]

Linked companies

Sources